<DOC>
<DOCNO>
EP-0002836
</DOCNO>
<TEXT>
<DATE>
19790711
</DATE>
<IPC-CLASSIFICATIONS>
C07C-233/12 A61P-1/16 C07C-231/00 C07D-211/76 A61K-31/205 A61K-31/195 C07C-235/00 C07C-233/49 <main>C07C-103/84</main> C07C-231/02 C07K-5/02 A61P-1/14 C07C-233/83 A61P-1/00 C07C-103/66 A01N-37/12 C07C-67/00 A61K-31/22 C07D-211/00 C07C-231/12 C07C-233/45 C07C-233/63 C07K-5/00 C07C-233/46 C07C-235/60 C07C-233/47 C07C-103/48 A61K-31/185 C07C-235/52 A61K-31/21 C07C-233/00 
</IPC-CLASSIFICATIONS>
<TITLE>
acylhydrocarbylaminoalcanecarboxylic acids, their preparation and their use, and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
byk gulden lomberg chem fabde<sep>byk gulden lomberg chemische fabrik gmbh<sep>byk gulden lomberg chemische fabrik gmbhpostfach 10 03 10d-78403 konstanzde<sep>byk gulden lomberg chemische fabrik gmbh<sep>
</APPLICANT>
<INVENTOR>
krastinat walter dr<sep>riedel richard dr<sep>krastinat, walter, dr.<sep>riedel, richard, dr.<sep>krastinat, walter, dr.erfurter strasse 9d-7750 konstanzde<sep>riedel, richard, dr.bruelstrasse 22d-7750 konstanzde<sep>krastinat, walter, dr.<sep>riedel, richard, dr.<sep>krastinat, walter, dr.erfurter strasse 9d-7750 konstanzde<sep>riedel, richard, dr.bruelstrasse 22d-7750 konstanzde<sep>
</INVENTOR>
<ABSTRACT>
compounds of the formula   <image> wherein r<1> is aliphatic or alicyclic hydrocarbyl or optionally substituted phenyl; r<2> is hydrogen or aliphatic hydrocarbyl; r<3> is hydrogen, alkyl, cycloalkyl, optionally substituted phenyl or, with r<4>, r<4> is alkyl, cycloalkyl, optionally substituted phenyl, optionally substituted phenalkyl or, with r<3>, alkylene; or r<2>, r<3> and r<4>, together with the carbon to which each is bond, are adamantyl; and n is 3, 4 or 5; and salts thereof with a base are pharmacologically active.  physiologically-acceptable embodiments are administered, e. g. , in the form of an appropriate pharmaceutical composition to warm-blooded animals for protection against and treatment for stomach, intestine, pancreas, bile and liver disorders.  syntheses of pharmacologically-active components, compounding such principles into pharmaceutical compositions and using such principles for preventing and treating the noted disorders are described. 
</ABSTRACT>
</TEXT>
</DOC>
